Enzalutamide API

Enzalutamide API is a key ingredient used in the production of drugs for treating prostate cancer. It belongs to the class of androgen receptor inhibitors, which can prevent androgens from binding to receptors, thereby inhibiting the growth and proliferation of prostate cancer cells. Clinically, drugs made from Enzalutamide API are mainly used for the treatment of metastatic castration-resistant prostate cancer. They can effectively delay the progression of the disease, improve the survival rate of patients, and enhance the physical condition and quality of life of patients.